Novartis AG v Pharmacor Pty Limited

Link copied
Case Copied 21 min read

FEDERAL COURT OF AUSTRALIA

Novartis AG v Pharmacor Pty Limited [2022] FCAFC 58

Appeal from: Application for leave to appeal from interlocutory order of primary judge made on 22 March 2022 in proceeding NSD 183 of 2021
File number: NSD 208 of 2022
Judgment of: YATES, BEACH AND MOSHINSKY JJ
Date of judgment: 4 April 2022
Date of publication of reasons: 8 April 2022
Catchwords: PRACTICE AND PROCEDURE – application for leave to appeal – patent litigation – where respondent/cross-claimant below filed expert evidence from one neurologist – where applicants/cross-respondents below filed expert evidence from four neurologists – where, at a case management hearing, docket judge excluded the evidence of two of the applicants’ neurologists and excluded the non-factual evidence of one of the applicants’ neurologists – whether decision of primary judge attended by sufficient doubt to warrant reconsideration by Full Court – whether substantial injustice would result if leave were refused – application for leave refused
Legislation:

Evidence Act 1995 (Cth), ss 79, 192A

Federal Court of Australia Act 1976 (Cth), Pt VB

Federal Court Rules 2011, r 5.04

Cases cited:

AstraZeneca AB v Apotex Pty Ltd (2015) 257 CLR 356

Australian Securities and Investments Commission v Australia and New Zealand Banking Group Ltd (2019) 139 ACSR 52

Decor Corporation Pty Ltd v Dart Industries Inc (1991) 33 FCR 397

Novartis AG v FH Faulding & Co Ltd [2004] FCAFC 254

Division: General Division
Registry: New South Wales
National Practice Area: Intellectual Property
Sub-area: Patents and associated Statutes
Number of paragraphs: 41
Date of hearing: 4 April 2022
Counsel for the Applicants: Mr C Dimitriadis SC with Mr BA Mee
Solicitor for the Applicants: Clayton Utz
Counsel for the Respondent: Mr JS Cooke with Mr DB Larish
Solicitor for the Respondent: Maddocks Lawyers

ORDERS

NSD 208 of 2022
BETWEEN:

NOVARTIS AG

First Applicant

NOVARTIS PHARMACEUTICALS AUSTRALIA PTY LIMITED (ACN 004 244 162)

Second Applicant

AND:

PHARMACOR PTY LIMITED (ACN 121 020 835)

Respondent

ORDER MADE BY:

YATES, BEACH AND MOSHINSKY JJ

DATE OF ORDER:

4 APRIL 2022

THE COURT ORDERS THAT:

1.The application for leave to appeal be refused.

2.The applicants pay the respondent’s costs of the application for leave to appeal.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


REASONS FOR JUDGMENT

YATES AND MOSHINSKY JJ:

  1. This is an application for leave to appeal from a decision of the primary judge on a matter of practice and procedure.  The application for leave to appeal was heard together with the appeal (if leave were granted).  At the conclusion of the hearing, after a short adjournment, the Full Court announced its decision and made orders that the application for leave to appeal be refused, and that the applicants pay the respondent’s costs of the application for leave to appeal.  The Court indicated that reasons would be published in due course.  The following are our reasons for joining in the orders.

  2. In the proceeding at first instance, the respondent (Pharmacor

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Novartis AG v Pharmacor Pty Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2022] FCAFC 58
Decision Date

CaseChat Overview and Summary

The matter of Novartis AG against Pharmacor Pty Limited involved a dispute in patent litigation, specifically focusing on the admissibility of expert evidence in a case management hearing. The case was heard by the Full Court of the Federal Court of Australia, which was tasked with deciding on an application for leave to appeal a decision made by the primary judge. The primary judge had excluded certain expert evidence from two of the applicants' neurologists and had also excluded the non-factual evidence of another of the applicants' neurologists. The applicants, who were the original litigants in the patent dispute, sought leave to appeal this decision, arguing that the primary judge's decision was flawed and warranted reconsideration by the Full Court.

The central legal issue before the Full Court was whether the decision of the primary judge was attended by sufficient doubt to warrant reconsideration, and whether a substantial injustice would result if leave to appeal was refused. The applicants argued that the exclusion of expert evidence was an error that could have a significant impact on the outcome of the case. They contended that the evidence from their experts was crucial to their case and that the exclusion of this evidence by the primary judge could lead to an unfair outcome. Conversely, the respondent argued that the primary judge's decision was correct and that there was no substantial injustice that would result from denying leave to appeal.

The Full Court, after considering the arguments presented, found that the decision of the primary judge was not attended by sufficient doubt to warrant reconsideration. The Court held that the primary judge had carefully considered the admissibility of the expert evidence and had made a reasoned decision based on the evidence presented. The Full Court also concluded that no substantial injustice would result from refusing leave to appeal. The Court noted that the applicants had not demonstrated that the exclusion of the expert evidence would lead to an unfair outcome, and that the remaining evidence was sufficient to allow the case to proceed fairly. Consequently, the application for leave to appeal was refused, and the applicants were ordered to pay the respondent's costs of the application.

Orders

Orders of the court

1. The application for leave to appeal be refused.

2. The applicants pay the respondent’s costs of the application for leave to appeal.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.